Retinal Vasculitis
📧 Sign up to get email alerts when something new happens for Retinal Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)
A completed real-world evidence study by Regeneron evaluated the incidence of retinal vasculitis in adults receiving aflibercept 2 mg in the…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study
A real-world evidence study evaluating the incidence of retinal vasculitis in patients treated with aflibercept (Eylea) in the United States…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Six-months Versus Nine-months ATT for Ocular TB [Phase 4]
Completed Phase 4 trial comparing six-month versus nine-month anti-tuberculosis therapy durations for ocular tuberculosis, evaluating condit…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis [Phase 4]
Phase 4 trial investigating efficacy and safety of H.P. ACTHAR GEL in adults with retinal vasculitis associated with posterior uveitis.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) [Phase 3]
Phase 3 trial comparing interferon alfa-2a versus cyclosporin A in severe ocular Behçet's disease (panuveitis) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Biological Markers in Retinal Vasculitis
A completed clinical trial update focusing on biological markers in retinal vasculitis. The study was sponsored by the National Eye Institut…